Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Disparities and Temporal Trends in the Use of Anticoagulation in Patients With Ischemic Stroke and Atrial Fibrillation.

Sur NB, Wang K, Di Tullio MR, Gutierrez CM, Dong C, Koch S, Gardener H, García-Rivera EJ, Zevallos JC, Burgin WS, Rose DZ, Goldberger JJ, Romano JG, Sacco RL, Rundek T.

Stroke. 2019 Jun;50(6):1452-1459. doi: 10.1161/STROKEAHA.118.023959. Epub 2019 May 14.

PMID:
31084325
2.

Indications for Mechanical Thrombectomy-Too Wide or Too Narrow?

Ren Z, Mokin M, Bauer CT, Miao Z, Burgin WS, Wang Y.

World Neurosurg. 2019 Jul;127:492-499. doi: 10.1016/j.wneu.2019.04.116. Epub 2019 Apr 19. Review.

PMID:
31009772
3.

Predictors of Thrombolysis Administration in Mild Stroke: Florida-Puerto Rico Collaboration to Reduce Stroke Disparities.

Asdaghi N, Wang K, Ciliberti-Vargas MA, Gutierrez CM, Koch S, Gardener H, Dong C, Rose DZ, Garcia EJ, Burgin WS, Zevallos JC, Rundek T, Sacco RL, Romano JG; FL-PR CReSD Investigators and Collaborators.

Stroke. 2018 Mar;49(3):638-645. doi: 10.1161/STROKEAHA.117.019341. Epub 2018 Feb 19.

4.

ASPECTS, Large Vessel Occlusion, and Time of Symptom Onset: Estimation of Eligibility for Endovascular Therapy.

Mokin M, Pendurthi A, Ljubimov V, Burgin WS, Siddiqui AH, Levy EI, Primiani CT.

Neurosurgery. 2018 Jul 1;83(1):122-127. doi: 10.1093/neuros/nyx352.

PMID:
29106687
5.

Racial-Ethnic Disparities in Acute Stroke Care in the Florida-Puerto Rico Collaboration to Reduce Stroke Disparities Study.

Sacco RL, Gardener H, Wang K, Dong C, Ciliberti-Vargas MA, Gutierrez CM, Asdaghi N, Burgin WS, Carrasquillo O, Garcia-Rivera EJ, Nobo U, Oluwole S, Rose DZ, Waters MF, Zevallos JC, Robichaux M, Waddy SP, Romano JG, Rundek T; FL‐PR CReSD Investigators and Collaborators.

J Am Heart Assoc. 2017 Feb 14;6(2). pii: e004073. doi: 10.1161/JAHA.116.004073.

6.

Gender-Specific Differences for Risk of Disability and Death in Atrial Fibrillation-Related Stroke.

Martin RC, Burgin WS, Schabath MB, Kirby B, Chae SH, Fradley MG, Rose DZ, Labovitz AJ.

Am J Cardiol. 2017 Jan 15;119(2):256-261. doi: 10.1016/j.amjcard.2016.09.049. Epub 2016 Oct 8.

PMID:
27846983
7.

Constitutional Chromoanagenesis of Distal 13q in a Young Adult with Recurrent Strokes.

Burnside RD, Harris A, Speyer D, Burgin WS, Rose DZ, Sanchez-Valle A.

Cytogenet Genome Res. 2016;150(1):46-51. doi: 10.1159/000452144. Epub 2016 Nov 9.

PMID:
27825145
8.

Sex Disparities in Ischemic Stroke Care: FL-PR CReSD Study (Florida-Puerto Rico Collaboration to Reduce Stroke Disparities).

Asdaghi N, Romano JG, Wang K, Ciliberti-Vargas MA, Koch S, Gardener H, Dong C, Rose DZ, Waddy SP, Robichaux M, Garcia EJ, Gonzalez-Sanchez JA, Burgin WS, Sacco RL, Rundek T.

Stroke. 2016 Oct;47(10):2618-26. doi: 10.1161/STROKEAHA.116.013059. Epub 2016 Aug 23.

9.

ASPECTS decay during inter-facility transfer in patients with large vessel occlusion strokes.

Mokin M, Gupta R, Guerrero WR, Rose DZ, Burgin WS, Sivakanthan S.

J Neurointerv Surg. 2017 May;9(5):442-444. doi: 10.1136/neurintsurg-2016-012331. Epub 2016 Apr 22.

PMID:
27106593
10.

Hemorrhagic stroke following use of the synthetic marijuana "spice".

Rose DZ, Guerrero WR, Mokin MV, Gooch CL, Bozeman AC, Pearson JM, Burgin WS.

Neurology. 2015 Sep 29;85(13):1177-9. doi: 10.1212/WNL.0000000000001973. Epub 2015 Aug 28. No abstract available.

11.

Author response.

Gooch CL, Freeman MJ, Rose DZ, Burgin WS.

Neurology. 2014 Aug 19;83(8):773. No abstract available.

PMID:
25275172
12.

Ischemic stroke after use of the synthetic marijuana "spice".

Freeman WD, Louh IK, Gooch CL, Freeman MJ, Rose DZ, Burgin WS.

Neurology. 2014 Aug 19;83(8):772-3. doi: 10.1212/01.wnl.0000453555.25241.99. No abstract available.

PMID:
25135913
13.

Ischemic stroke after use of the synthetic marijuana "spice".

Freeman MJ, Rose DZ, Myers MA, Gooch CL, Bozeman AC, Burgin WS.

Neurology. 2013 Dec 10;81(24):2090-3. doi: 10.1212/01.wnl.0000437297.05570.a2. Epub 2013 Nov 8.

14.

Effects of age on outcome in the SENTIS trial: better outcomes in elderly patients.

Leker RR, Molina C, Cockroft K, Liebeskind DS, Concha M, Shuaib A, De Deyn PP, Burgin WS, Gupta R, Dillon W, Diener HC.

Cerebrovasc Dis. 2012;34(4):263-71. doi: 10.1159/000342668. Epub 2012 Oct 11.

15.

Safety and feasibility of NeuroFlo use in eight- to 24-hour ischemic stroke patients.

Hammer MD, Schwamm L, Starkman S, Schellinger PD, Jovin T, Nogueira R, Burgin WS, Sen S, Diener HC, Watson T, Michel P, Shuaib A, Dillon W, Liebeskind DS.

Int J Stroke. 2012 Dec;7(8):655-61. doi: 10.1111/j.1747-4949.2011.00719.x. Epub 2012 Jan 20.

16.

A cost-effectiveness analysis of carotid artery stenting compared with endarterectomy.

Young KC, Holloway RG, Burgin WS, Benesch CG.

J Stroke Cerebrovasc Dis. 2010 Sep-Oct;19(5):404-9. doi: 10.1016/j.jstrokecerebrovasdis.2009.08.003.

17.

Perceptual relearning of complex visual motion after V1 damage in humans.

Huxlin KR, Martin T, Kelly K, Riley M, Friedman DI, Burgin WS, Hayhoe M.

J Neurosci. 2009 Apr 1;29(13):3981-91. doi: 10.1523/JNEUROSCI.4882-08.2009.

18.

Neuroprotection and the ischemic cascade.

Felberg RA, Burgin WS, Grotta JC.

CNS Spectr. 2000 Mar;5(3):52-8.

PMID:
18277329
19.

Prognosis and decision making in severe stroke.

Holloway RG, Benesch CG, Burgin WS, Zentner JB.

JAMA. 2005 Aug 10;294(6):725-33. Review.

PMID:
16091575
20.

Ultrasound-enhanced thrombolysis for acute ischemic stroke: phase I. Findings of the CLOTBUST trial.

Alexandrov AV, Demchuk AM, Burgin WS, Robinson DJ, Grotta JC; CLOTBUST Investigators.

J Neuroimaging. 2004 Apr;14(2):113-7.

PMID:
15095555
21.

Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study.

Cramer SC, Rordorf G, Maki JH, Kramer LA, Grotta JC, Burgin WS, Hinchey JA, Benesch C, Furie KL, Lutsep HL, Kelly E, Longstreth WT Jr.

Stroke. 2004 Jan;35(1):46-50. Epub 2003 Dec 4.

PMID:
14657451
22.

Paradoxical emboli from calf and pelvic veins in cryptogenic stroke.

Cramer SC, Maki JH, Waitches GM, D'Souza N, Grotta JC, Burgin WS, Kramer LA.

J Neuroimaging. 2003 Jul;13(3):218-23.

PMID:
12889167
23.

Improving efficiency of stroke research: the Brain Attack Surveillance in Corpus Christi study.

Al-Wabil A, Smith MA, Moyé LA, Burgin WS, Morgenstern LB.

J Clin Epidemiol. 2003 Apr;56(4):351-7.

PMID:
12767412
24.

Pilot dose-escalation study of caffeine plus ethanol (caffeinol) in acute ischemic stroke.

Piriyawat P, Labiche LA, Burgin WS, Aronowski JA, Grotta JC.

Stroke. 2003 May;34(5):1242-5. Epub 2003 Apr 10.

PMID:
12690224
25.

Insonation method and diagnostic flow signatures for transcranial power motion (M-mode) Doppler.

Alexandrov AV, Demchuk AM, Burgin WS.

J Neuroimaging. 2002 Jul;12(3):236-44.

PMID:
12116742
26.

Early dramatic recovery during intravenous tissue plasminogen activator infusion: clinical pattern and outcome in acute middle cerebral artery stroke.

Felberg RA, Okon NJ, El-Mitwalli A, Burgin WS, Grotta JC, Alexandrov AV.

Stroke. 2002 May;33(5):1301-7.

PMID:
11988607
27.

Intravenous tissue plasminogen activator and flow improvement in acute ischemic stroke patients with internal carotid artery occlusion.

Christou I, Felberg RA, Demchuk AM, Burgin WS, Malkoff M, Grotta JC, Alexandrov AV.

J Neuroimaging. 2002 Apr;12(2):119-23.

PMID:
11977905
28.

Improving delivery of acute stroke therapy: The TLL Temple Foundation Stroke Project.

Morgenstern LB, Staub L, Chan W, Wein TH, Bartholomew LK, King M, Felberg RA, Burgin WS, Groff J, Hickenbottom SL, Saldin K, Demchuk AM, Kalra A, Dhingra A, Grotta JC.

Stroke. 2002 Jan;33(1):160-6.

PMID:
11779906
29.

Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000.

Grotta JC, Burgin WS, El-Mitwalli A, Long M, Campbell M, Morgenstern LB, Malkoff M, Alexandrov AV.

Arch Neurol. 2001 Dec;58(12):2009-13.

PMID:
11735774
30.

Acute stroke care in non-urban emergency departments.

Burgin WS, Staub L, Chan W, Wein TH, Felberg RA, Grotta JC, Demchuk AM, Hickenbottom SL, Morgenstern LB.

Neurology. 2001 Dec 11;57(11):2006-12.

PMID:
11739817
31.

Hypothermia after cardiac arrest: feasibility and safety of an external cooling protocol.

Felberg RA, Krieger DW, Chuang R, Persse DE, Burgin WS, Hickenbottom SL, Morgenstern LB, Rosales O, Grotta JC.

Circulation. 2001 Oct 9;104(15):1799-804.

PMID:
11591617
32.

Arterial status after intravenous TPA therapy for ischaemic stroke. A need for further interventions.

Christou I, Burgin WS, Alexandrov AV, Grotta JC.

Int Angiol. 2001 Sep;20(3):208-13.

PMID:
11573054
33.

A broad diagnostic battery for bedside transcranial Doppler to detect flow changes with internal carotid artery stenosis or occlusion.

Christou I, Felberg RA, Demchuk AM, Grotta JC, Burgin WS, Malkoff M, Alexandrov AV.

J Neuroimaging. 2001 Jul;11(3):236-42.

PMID:
11462288
34.

Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement.

Alexandrov AV, Burgin WS, Demchuk AM, El-Mitwalli A, Grotta JC.

Circulation. 2001 Jun 19;103(24):2897-902.

PMID:
11413077
35.

Deterioration following improvement with tPA therapy: carotid thrombosis and reocclusion.

Burgin WS, Alexandrov AV.

Neurology. 2001 Feb 27;56(4):568-70. No abstract available.

PMID:
11222812
36.

Deterioration following spontaneous improvement : sonographic findings in patients with acutely resolving symptoms of cerebral ischemia.

Alexandrov AV, Felberg RA, Demchuk AM, Christou I, Burgin WS, Malkoff M, Wojner AW, Grotta JC.

Stroke. 2000 Apr;31(4):915-9.

PMID:
10753998
37.
38.

Timing of recanalization after tissue plasminogen activator therapy determined by transcranial doppler correlates with clinical recovery from ischemic stroke.

Christou I, Alexandrov AV, Burgin WS, Wojner AW, Felberg RA, Malkoff M, Grotta JC.

Stroke. 2000 Aug;31(8):1812-6.

PMID:
10926939
39.

Transcranial doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke.

Burgin WS, Malkoff M, Felberg RA, Demchuk AM, Christou I, Grotta JC, Alexandrov AV.

Stroke. 2000 May;31(5):1128-32.

PMID:
10797176
40.

High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial doppler monitoring.

Alexandrov AV, Demchuk AM, Felberg RA, Christou I, Barber PA, Burgin WS, Malkoff M, Wojner AW, Grotta JC.

Stroke. 2000 Mar;31(3):610-4.

PMID:
10700493

Supplemental Content

Loading ...
Support Center